UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Cape ANN Savings Bank

Cape ANN Savings Bank decreased its stake in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 4.1% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,595 shares of the healthcare conglomerate’s stock after selling 194 shares during the period. UnitedHealth Group accounts for 1.5% of Cape ANN Savings Bank’s portfolio, making the stock its 18th largest position. Cape ANN Savings Bank’s holdings in UnitedHealth Group were worth $2,343,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also made changes to their positions in UNH. Advocacy Wealth Management Services LLC lifted its holdings in shares of UnitedHealth Group by 75.8% in the 1st quarter. Advocacy Wealth Management Services LLC now owns 58 shares of the healthcare conglomerate’s stock worth $30,000 after purchasing an additional 25 shares during the last quarter. Cascade Investment Advisors Inc. raised its stake in UnitedHealth Group by 100.0% during the 1st quarter. Cascade Investment Advisors Inc. now owns 60 shares of the healthcare conglomerate’s stock valued at $31,000 after acquiring an additional 30 shares in the last quarter. Rise Advisors LLC bought a new stake in UnitedHealth Group during the 4th quarter valued at $38,000. Evolution Advisers Inc. bought a new stake in UnitedHealth Group during the 1st quarter valued at $38,000. Finally, Cordant Inc. bought a new stake in UnitedHealth Group during the 1st quarter valued at $45,000. Institutional investors own 87.25% of the company’s stock.

Insiders Place Their Bets

In other UnitedHealth Group news, CEO Andrew Witty sold 11,376 shares of the business’s stock in a transaction dated Monday, July 18th. The stock was sold at an average price of $527.90, for a total value of $6,005,390.40. Following the completion of the sale, the chief executive officer now owns 76,559 shares of the company’s stock, valued at $40,415,496.10. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In related news, CEO Andrew Witty sold 11,376 shares of the business’s stock in a transaction dated Monday, July 18th. The stock was sold at an average price of $527.90, for a total transaction of $6,005,390.40. Following the completion of the transaction, the chief executive officer now owns 76,559 shares of the company’s stock, valued at approximately $40,415,496.10. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Stephen J. Hemsley sold 99,312 shares of the business’s stock in a transaction dated Tuesday, July 26th. The stock was sold at an average price of $534.27, for a total value of $53,059,422.24. Following the transaction, the director now directly owns 787,372 shares of the company’s stock, valued at approximately $420,669,238.44. The disclosure for this sale can be found here. Insiders sold 140,324 shares of company stock valued at $75,086,185 over the last quarter. Insiders own 0.40% of the company’s stock.

UnitedHealth Group Price Performance

UNH opened at $513.96 on Wednesday. The stock has a market cap of $480.75 billion, a price-to-earnings ratio of 26.84, a PEG ratio of 1.64 and a beta of 0.76. UnitedHealth Group Incorporated has a 1 year low of $383.12 and a 1 year high of $553.29. The company has a current ratio of 0.77, a quick ratio of 0.77 and a debt-to-equity ratio of 0.60. The stock has a fifty day moving average price of $529.18 and a 200 day moving average price of $511.00.

UnitedHealth Group (NYSE:UNHGet Rating) last released its quarterly earnings data on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.24 by $0.33. The firm had revenue of $80.33 billion during the quarter, compared to analysts’ expectations of $79.68 billion. UnitedHealth Group had a return on equity of 25.45% and a net margin of 5.95%. The business’s revenue for the quarter was up 12.6% on a year-over-year basis. During the same quarter last year, the firm earned $4.70 earnings per share. Analysts forecast that UnitedHealth Group Incorporated will post 21.85 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 20th. Shareholders of record on Monday, September 12th will be given a $1.65 dividend. The ex-dividend date is Friday, September 9th. This represents a $6.60 dividend on an annualized basis and a dividend yield of 1.28%. UnitedHealth Group’s dividend payout ratio is currently 34.46%.

Wall Street Analyst Weigh In

Several brokerages have weighed in on UNH. UBS Group lifted their target price on UnitedHealth Group from $545.00 to $570.00 and gave the company a “neutral” rating in a research note on Thursday, July 21st. Deutsche Bank Aktiengesellschaft boosted their price objective on UnitedHealth Group from $556.00 to $569.00 and gave the stock a “buy” rating in a research note on Thursday, September 8th. Mizuho boosted their price objective on UnitedHealth Group from $550.00 to $600.00 and gave the stock a “buy” rating in a research note on Wednesday, August 10th. Oppenheimer boosted their price objective on UnitedHealth Group from $600.00 to $610.00 and gave the stock an “outperform” rating in a research note on Monday, July 18th. Finally, Credit Suisse Group boosted their price objective on UnitedHealth Group from $575.00 to $579.00 and gave the stock an “outperform” rating in a research note on Monday, July 18th. Three equities research analysts have rated the stock with a hold rating, fifteen have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $585.65.

UnitedHealth Group Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Featured Articles

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.